Print

Agios Pharmaceuticals Research in Cancer Metabolism Highlighted at American Association for Cancer Research Annual Meeting 2012  
4/3/2012 10:04:45 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the field of cancer metabolism, announced today that preclinical data from Agios research were highlighted in two poster sessions and an oral presentation at the American Association for Cancer Research (AACR) Annual Meeting 2012 being held March 31-April 4, 2012 in Chicago. The conference also featured two symposia specifically dedicated to research in the field of cancer metabolism.